Marathon Patent Group Inc. (NASDAQ:MARA) released its quarterly earnings results on Monday. The company reported ($0.42) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.25) by $0.17. Marathon Patent Group had a positive return on equity of 30.32% and a negative net margin of 7.30%.

Shares of Marathon Patent Group (NASDAQ:MARA) opened at 2.45 on Tuesday. The firm’s market cap is $36.87 million. The stock’s 50 day moving average price is $2.39 and its 200-day moving average price is $2.60. Marathon Patent Group has a 52-week low of $1.29 and a 52-week high of $3.44.

Earnings History for Marathon Patent Group (NASDAQ:MARA)

Several institutional investors have recently bought and sold shares of MARA. Eagle Global Advisors LLC purchased a new position in shares of Marathon Patent Group during the third quarter worth about $118,000. Vanguard Group Inc. boosted its position in shares of Marathon Patent Group by 3.5% in the second quarter. Vanguard Group Inc. now owns 204,734 shares of the company’s stock worth $561,000 after buying an additional 6,900 shares during the last quarter. Finally, Cambridge Investment Research Advisors Inc. boosted its position in shares of Marathon Patent Group by 17.5% in the second quarter. Cambridge Investment Research Advisors Inc. now owns 848,449 shares of the company’s stock worth $2,325,000 after buying an additional 126,565 shares during the last quarter. 8.97% of the stock is owned by institutional investors.

Marathon Patent Group Company Profile

Marathon Patent Group Inc (MARA) is engaged in acquiring patents and patent rights from owners or other ventures. The Company monetizes its portfolio of patents and patent rights by entering into license discussions. The Company owns around 378 United States and foreign patents, and patent rights across a range of technologies and markets.

5 Day Chart for NASDAQ:MARA

Receive News & Stock Ratings for Marathon Patent Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marathon Patent Group Inc. and related stocks with our FREE daily email newsletter.